Cancer Biotechnology
Science, Innovation, Curiosity
Leveraging gene tools to design new therapeutic interventions
projects
Research
We are employing vectors to genetically engineer cancer and immune cells to explore new therapeutic interventions and unravel new biological insights.
our group
Team
We are a group of scientists and students with academic formation in biomedical sciences. Ours is not another job, but a responsibility. A big one.
Our lab
About us
Our team is part of the Unit of Prof. Luigi Naldini, director of the San Raffaele Telethon Institute for Gene Therapy, located at the IRCCS San Raffaele, in Italy, Milan.
Selected Publications
Soldi M, Sergi Sergi L, Unali G, Kerzel T, Cuccovillo I, Capasso P, Annoni A, Biffi M, Rancoita PMV, Cantore A, Lombardo A, Naldini L, Squadrito ML*, Kajaste-Rudnitski A*.
A.Mol Ther Methods Clin Dev. 2020 Oct 20;19:411-425.
EVIR: chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens.
www.cancerbiotechnology.com – Thanks for visiting our website!